Workshop Goal
To bring together clinicians, researchers, regulators, industry representatives, and public health partners to identify barriers to clinical trial development for mucormycosis and other rare mold infections and develop an actionable roadmap for advancing clinical research and trial infrastructure.
Expected Outputs
• Consensus recommendations for advancing clinical trials in rare mold infections
• Minimum Common Dataset for registry and clinical trial data collection
• Candidate biomarker and endpoint framework
• Trial concept canvases for mucormycosis and other rare mold infections
• Working groups and action plan to support future protocol development
• Published workshop report and roadmap manuscript
